202 related articles for article (PubMed ID: 21080924)
1. Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance.
Karamitsos TD; Ntusi NA; Francis JM; Holloway CJ; Myerson SG; Neubauer S
J Cardiovasc Magn Reson; 2010 Nov; 12(1):66. PubMed ID: 21080924
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and safety of adenosine cardiovascular magnetic resonance in patients with MR conditional pacemaker systems at 1.5 Tesla.
Klein-Wiele O; Garmer M; Urbien R; Busch M; Kara K; Mateiescu S; Grönemeyer D; Schulte-Hermes M; Garbrecht M; Hailer B
J Cardiovasc Magn Reson; 2015 Dec; 17():112. PubMed ID: 26695427
[TBL] [Abstract][Full Text] [Related]
3. A comparison of standard and high dose adenosine protocols in routine vasodilator stress cardiovascular magnetic resonance: dosage affects hyperaemic myocardial blood flow in patients with severe left ventricular systolic impairment.
Brown LAE; Saunderson CED; Das A; Craven T; Levelt E; Knott KD; Dall'Armellina E; Xue H; Moon JC; Greenwood JP; Kellman P; Swoboda PP; Plein S
J Cardiovasc Magn Reson; 2021 Mar; 23(1):37. PubMed ID: 33731141
[TBL] [Abstract][Full Text] [Related]
4. Deactivation vs. asynchronous pacing - prospective evaluation of a protocol for rhythm management in patients with magnetic resonance conditional pacemakers undergoing adenosine stress cardiovascular magnetic resonance imaging.
Klein-Wiele O; Garmer M; Barbone G; Urbien R; Busch M; Kara K; Schäfer H; Schulte-Hermes M; Hailer B; Grönemeyer D
BMC Cardiovasc Disord; 2017 Jun; 17(1):142. PubMed ID: 28577544
[TBL] [Abstract][Full Text] [Related]
5. Inadequate response to adenosine infusion during cardiac stress magnetic resonance imaging.
Gupta S; Simha PP; Singh NG; Nagaraja PS; Barthur A; Ganga K; Prabhakar V
Ann Card Anaesth; 2022; 25(3):330-334. PubMed ID: 35799562
[TBL] [Abstract][Full Text] [Related]
6. Tolerance and safety of adenosine stress perfusion cardiovascular magnetic resonance imaging in patients with severe coronary artery disease.
Karamitsos TD; Arnold JR; Pegg TJ; Cheng AS; van Gaal WJ; Francis JM; Banning AP; Neubauer S; Selvanayagam JB
Int J Cardiovasc Imaging; 2009 Mar; 25(3):277-83. PubMed ID: 19037746
[TBL] [Abstract][Full Text] [Related]
7. The safety and tolerability of adenosine as a pharmacological stressor in stress perfusion cardiac magnetic resonance imaging in the Chinese population.
Tsang KH; Chan WS; Shiu CK; Chan MK
Hong Kong Med J; 2015 Dec; 21(6):524-7. PubMed ID: 26273015
[TBL] [Abstract][Full Text] [Related]
8. Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance.
Vasu S; Bandettini WP; Hsu LY; Kellman P; Leung S; Mancini C; Shanbhag SM; Wilson J; Booker OJ; Arai AE
J Cardiovasc Magn Reson; 2013 Sep; 15(1):85. PubMed ID: 24063278
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head comparison of first-pass MR perfusion imaging during adenosine and high-dose dobutamine/atropine stress.
Manka R; Jahnke C; Gebker R; Schnackenburg B; Paetsch I
Int J Cardiovasc Imaging; 2011 Oct; 27(7):995-1002. PubMed ID: 21088993
[TBL] [Abstract][Full Text] [Related]
10. Adenosine triphosphate (ATP) and adenosine cause similar vasodilator effect in patients undergoing stress perfusion cardiac magnetic resonance imaging.
García-Baizán A; Millor M; Bartolomé P; Ezponda A; Pueyo JC; Gavira JJ; Bastarrika G
Int J Cardiovasc Imaging; 2019 Apr; 35(4):675-682. PubMed ID: 30426300
[TBL] [Abstract][Full Text] [Related]
11. Stress Perfusion CMR in Patients With Known and Suspected CAD: Prognostic Value and Optimal Ischemic Threshold for Revascularization.
Vincenti G; Masci PG; Monney P; Rutz T; Hugelshofer S; Gaxherri M; Muller O; Iglesias JF; Eeckhout E; Lorenzoni V; Pellaton C; Sierro C; Schwitter J
JACC Cardiovasc Imaging; 2017 May; 10(5):526-537. PubMed ID: 28412420
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic effects of pharmacologic stress with adenosine in patients with left ventricular systolic dysfunction.
Gulsin GS; Abdelaty AMSEK; Shetye A; Lai FY; Bajaj A; Das I; Deshpande A; Rao PPG; Khoo J; McCann GP; Arnold JR
Int J Cardiol; 2019 Mar; 278():157-161. PubMed ID: 30528627
[TBL] [Abstract][Full Text] [Related]
13. Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery.
Nanni S; Lovato L; Ghetti G; Vagnarelli F; Mineo G; Fattori R; Saia F; Marzocchi A; Marrozzini C; Zompatori M; Reggiani LB; Semprini F; Melandri G; Biagini E; Corsini A; Norscini G; Rapezzi C
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1589-1597. PubMed ID: 28455632
[TBL] [Abstract][Full Text] [Related]
14. Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease.
Levelt E; Piechnik SK; Liu A; Wijesurendra RS; Mahmod M; Ariga R; Francis JM; Greiser A; Clarke K; Neubauer S; Ferreira VM; Karamitsos TD
J Cardiovasc Magn Reson; 2017 Oct; 19(1):81. PubMed ID: 29070069
[TBL] [Abstract][Full Text] [Related]
15. Relationship between gated myocardial perfusion SPECT findings and hemodynamic, electrocardiographic, and heart rate changes after Dipyridamole infusion.
Gholoobi A; Ayati N; Baghyari A; Mouhebati M; Atar B; Dabbagh Kakhki VR
Int J Cardiovasc Imaging; 2017 Jun; 33(6):951-956. PubMed ID: 28150082
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance.
Freed BH; Narang A; Bhave NM; Czobor P; Mor-Avi V; Zaran ER; Turner KM; Cavanaugh KP; Chandra S; Tanaka SM; Davidson MH; Lang RM; Patel AR
J Cardiovasc Magn Reson; 2013 Dec; 15(1):108. PubMed ID: 24359617
[TBL] [Abstract][Full Text] [Related]
17. The adverse events and hemodynamic effects of adenosine-based cardiac MRI.
Voigtländer T; Schmermund A; Bramlage P; Elsässer A; Magedanz A; Kauczor HU; Mohrs OK
Korean J Radiol; 2011; 12(4):424-30. PubMed ID: 21852902
[TBL] [Abstract][Full Text] [Related]
18. Cardiac magnetic resonance for asymptomatic patients with type 2 diabetes and cardiovascular high risk (CATCH): a pilot study.
Ng MY; Zhou W; Vardhanabhuti V; Lee CH; Yu EYT; Wan EYF; Chan K; Yan AT; Ip TP; Yiu KH; Wintersperger BJ
Cardiovasc Diabetol; 2020 Mar; 19(1):42. PubMed ID: 32234045
[TBL] [Abstract][Full Text] [Related]
19. Clinical values of resting electrocardiography in patients with known or suspected chronic coronary artery disease: a stress perfusion cardiac MRI study.
Kaolawanich Y; Thongsongsang R; Songsangjinda T; Boonyasirinant T
BMC Cardiovasc Disord; 2021 Dec; 21(1):621. PubMed ID: 34963469
[TBL] [Abstract][Full Text] [Related]
20. Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping.
van Dijk R; Kuijpers D; Kaandorp TAM; van Dijkman PRM; Vliegenthart R; van der Harst P; Oudkerk M
Int J Cardiovasc Imaging; 2017 Nov; 33(11):1753-1759. PubMed ID: 28547666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
